Outcomes with Radium-223 therapy in clinical practice of metastatic castration resistant prostate cancer (mCRPC).

被引：0
|
作者：
Alva, Ajjai Shivaram
Nordquist, Luke T.
Daignault, Stephanie
George, Saby
Ramos, Jorge
Isharwal, Sudhir
McDonald, Matthew
Campbell, Gregory
Danchaivijitr, Pongwut
Albany, Costantine
Yu, Evan Y.
机构：
[1] Univ Michigan, Dept Internal Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[2] Urol Canc Ctr, Omaha, NE USA
[3] GU Res Network, Omaha, NE USA
[4] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA
[5] Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Urol Canc Ctr, Omaha, NE USA
[8] Univ Michigan, Ann Arbor, MI 48109 USA
[9] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[10] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e16073
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16073
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Pharmacodynamic study of radium-223 in men with bone metastatic castration resistant prostate cancer
    Armstrong, Andrew J.
    Gupta, Santosh
    Healy, Patrick
    Kemeny, Gabor
    Leith, Beth
    Zalutsky, Michael R.
    Spritzer, Charles
    Davies, Catrin
    Rothwell, Colin
    Ware, Kathryn
    Somarelli, Jason A.
    Wood, Kris
    Ribar, Thomas
    Giannakakou, Paraskevi
    Zhang, Jiaren
    Gerber, Drew
    Anand, Monika
    Foo, Wen-Chi
    Halabi, Susan
    Gregory, Simon G.
    George, Daniel J.
    PLOS ONE, 2019, 14 (05):
  • [42] Evaluating radium-223 response in metastatic castration-resistant prostate cancer with imaging
    Iizuka, Junpei
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 16 - 23
  • [43] Practical recommendations for radium-223 treatment of metastatic castration-resistant prostate cancer
    Du, Yong
    Carrio, Ignasi
    De Vincentis, Giuseppe
    Fanti, Stefano
    Ilhan, Harun
    Mommsen, Caroline
    Nitzsche, Egbert
    Sundram, Francis
    Vogel, Wouter
    Oyen, Wim
    Lewington, Val
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 (10) : 1671 - 1678
  • [44] Impact of germline mutations in homologous recombination (HR) genes on the response to Radium-223 for metastatic castration resistant prostate cancer (mCRPC)
    Castro, E.
    Lozano Mejorada, R.
    Saez, M.
    De Giorgi, U. F. F.
    Aragon, I.
    Romero Laorden, N.
    De Velasco Oria de Rueda, G. A.
    Magraner, L.
    Pacheco, M. I.
    Puente, J.
    Gonzalez del Alba, A.
    Borrega Garcia, P.
    Conteduca, V.
    Villa Guzman, J. C.
    Fernandez Parra, E.
    Rodriguez-Vida, A.
    Medina Colmenero, A.
    Morales Barrera, R.
    Lorente, D.
    Olmos Hidalgo, D.
    ANNALS OF ONCOLOGY, 2019, 30
  • [45] Safety outcomes and pain responses in the REASSURE observational study of radium-223 (Ra-223) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Conti, Peter
    George, Saby
    Tomaszewski, Jeffrey
    Song, Daniel
    Harshman, Lauren
    Nordquist, Luke
    Sandstrom, Per
    Bayh, Inga
    Babajanyan, Svetlana
    Sartor, Oliver
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
  • [46] Radium-223 therapy in Metastatic Castration-Resistant Prostate Cancer: effects on tumor and normal cell lines
    Balteiro, G.
    Marques, I.
    Abrantes, M.
    Neves, A.
    Meireles, I.
    Pires, A.
    Costa, G.
    Tavares-Silva, E.
    Figueiredo, A.
    Botelho, M.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 30 - 30
  • [47] Managing Radium-223 Therapy in patients with Metastatic Castration-Resistant Prostate Cancer - Developing a multiprofessional team
    Cruz, M. Botelho
    Aniceto, D.
    Nunes, A.
    Mills, C.
    Lewington, V.
    Fahim, H.
    Allen, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S665 - S665
  • [48] Prediction of hematological toxicity in Radium-223 therapy in patients with advanced metastatic castration-resistant prostate cancer
    Fosbol, M. O.
    Petersen, P. M.
    Kjaer, A.
    Mortensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S330 - S330
  • [49] Radium-223 Is the Preferred Therapy in Bone-Predominant Symptomatic Metastatic Castration-Resistant Prostate Cancer
    Dreicer, Robert
    Li, Jing
    Andrew, J.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2015, 13 (05) : 293 - +
  • [50] Impact of treatment delay in Radium-223 Dichloride therapy of metastatic castration-resistant prostate cancer patients
    Fosbol, M. O.
    Holm, S.
    Petersen, P. M.
    Daugaard, G.
    Mortensen, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
12345